Testopel 75mg Group for Low Testosterone

"As of right now, this clinical trial is not admitting any more patients. It was first posted on March 12th, 2020 and was updated on October 17th, 2022. For those looking for other trials, there are 37 trials for hypogonadism and 33 trials for Testopel that are still admitting patients."

"At present, there are 33 active clinical trials for Testopel. Of these, 5 are in Phase 3. The majority of Testopel trials are being conducted in Houston, Texas; however, there are158 total locations running studies for this medication."

"Researchers conducting this study are in need of 120 individuals that have hypogonadism and are between the ages of 18 and 75. Furthermore, it is crucial that potential participants meet the following requirements: They must be able to sign the study's consent form(s), which have been approved by an Institutional Review Board (IRB). Prior to the beginning of any procedures, written consent must be given. The individual must also be male, naïve to androgen replacement or have completed a washout period of 4 weeks after androgen treatment."

"There is already some data to support Testopel's efficacy, as well as numerous data sets providing evidence of its safety. Therefore, we have rated Testopel as a 3 on our Power scale."

"Testopel is frequently used to manage hypothalamo-pituitary disorders. Additionally, it has been found to be an effective intervention for managing other conditions such as delayed puberty, breast cancer, and asthma."

"The age bracket for people that can qualify for this clinical trial is 18 to 75. However, there are 3 separate clinical trials for minors and 45 different trials for elderly patients."

"At this time, this study is not looking for any new candidates. According to the study's post on clinicaltrials.gov, the last update was on October 17th, 2020. If you are looking for other studies, 37 trials for hypogonadism and 33 for Testopel are currently underway."